Impact of co-administration of two amino acid solutions on the elimination and adverse effects of 177Lu-Dotatate 177Lu-Dotatate Somatostatin analogs population pharmacokinetic analysis relationship pharmacokinetic/pharmacodynamics neuroendocrin tumor theranostic...
Role of genetic mutations in trabectedin liver toxicity. ABC transporters advanced soft tissue sarcomas CYP450 hepatotoxicity next-generation sequencing trabectedine Maud Mailard Fabienne Thomas – tean : DIAD : Individualisation of cancer drug doses Trabectedin...
The value of screening for DPD activity in all patients treated with fluoropyrimidines. 5-Fluorouracile breast cancer capecitabine DPD deficiency Maud MAILLARD – t team DIAD Dose-Individualization of Anti-cancer Drugs, CRCT Fluoropyrimidines (mainly...
A look back at the adventure of 17 young secondary school students at the heart of cancer research as part of the Apprentice Researchers scheme deployed for the first time at the CRCT. To be discovered on the dedicated page (in french only) Toulouse Cancer Research...
To improve your browsing experience. Cookies provide information on how the site is used: statistics such as the number of visitors, the average length of visits or the number of pages viewed. On the other hand, disabling cookies may prevent you from using certain features, such as sharing content via social networks.
You can adjust all your cookie settings by navigating the tabs on the left.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This site uses Google Analytics to collect anonymous information such as the number of visitors to the site and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!